Diego Abad-Montero

Diego Abad-Montero

Auto-generated profile, based on publicly available information

Diego Abad-Montero

Departament de Química Inorgànica i Orgànica, Secció de Química Orgànica, Universitat de Barcelona (UB) and Institut de Biomedicina de la Universitat de Barcelona (IBUB) Barcelona Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2025 in Inorganic Chemistry Frontiers
Verified
Journal Article
Open access
PDF file
GVGloria Vigueras
Gloria Vigueras
EGEduardo Izquierdo García
Eduardo Izquierdo García
ETElena de la Torre-Rubio
Elena de la Torre-Rubio
DADiego Abad-Montero
Diego Abad-Montero
MSMaria Dolores Santana
Maria Dolores Santana
JRJosé Ruiz
José Ruiz
Metal–coumarin photosensitizers enhance ROS generation and phototoxicity, offering promising solutions for cancer phototherapy.

4 March 2025 in Inorganic Chemistry Frontiers
Verified
Journal Article
Open access
PDF file
EOEnrique Ortega-Toro
Enrique Ortega-Toro
ARAnna Rovira
Anna Rovira
PAPezhman Ashoo
Pezhman Ashoo
EGEduardo Izquierdo García
Eduardo Izquierdo García
CHCormac Hally
Cormac Hally
VMVicente Marchán
Vicente Marchán
Despite the potential of photodynamic therapy (PDT), this oxygen-dependent oncological treatment is greatly restricted in the clinic by the well-known hypoxic feature of solid tumors. Here we provide new insights on the development of PDT agents based on conjugates between COUPY fluorophores and cyclometalated iridium(III) complexes with the aim of overcoming this limitation. The structural modifications carried out within the metal core of Ir(III)-COUPY conjugates, based on the incorporation of trifluorobenzyl groups at the cyclometalating ligands, allowed efficient explotation of Type I PDT mechanisms while retaining operativity at long-wavelength visible light, which facilitates deeper tissue penetration compared with short wavelengths. Photobiological evaluation revealed that Ir(III)‑COUPY conjugate 3c achieved potent photocytotoxicity towards cisplatin-resistant ovarian (A2780cis) and mammary (EO771) cancer cell lines, efficiently photogenerated Type I and Type II ROS and photoinduced apoptotic cell death using red light irradiation (620 nm). Importantly, this Ir(III)-COUPY conjugate retained such potent photoactivity under low-oxygen environment conditions (2% O2), delivering equipotent photocytotoxicity towards normoxic and hypoxic adherent cancer cells. Compound 3c was found highly phototoxic against EO771 multicellular tumor spheroids and showed no signs of toxicity or adverse effects in mice, which could facilitate in vivo phototherapeutic applications. Taken together, this study demonstrated that the conjugation between COUPY dyes and rationally-designed Ir(III) complexes represents a frontier strategy for the development of new red light‑activated photosensitizers capable of operating under hypoxia, holding promise to achieve satisfactory anticancer PDT effects.

8 December 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
DADiego Abad-Montero
Diego Abad-Montero
EGEduardo Izquierdo García
Eduardo Izquierdo García
PMPierre Mesdom
Pierre Mesdom
AGAlbert Gandioso
Albert Gandioso
ETElena de la Torre-Rubio
Elena de la Torre-Rubio
VMVicente Marchán
Vicente Marchán
Photodynamic therapy (PDT) is a promising cancer treatment modality, offering precise spatial and temporal control of drug activation using light. However, clinical translation of current photosensitizers (PSs) is limited by inefficient activation at wavelengths within the phototherapeutic window, especially in the deep-red and near-infrared (NIR) region. NIR light provides advantages such as reduced absorption by endogenous chromophores, minimized tissue photodamage, and improved tissue penetration, highlighting the need for PSs to be activatable in this range. Herein, we report a novel series of ruthenium(II) polypyridyl complexes (Ru4-7) featuring π-extended COUBPY ligands, designed via a vinylogation strategy and synthesized through an innovative postcoordination ligand assembly approach. This structural modification enhances molar absorptivity and red-shifts the absorption bands well into the NIR region without substantially compromising photostability. Complexes Ru4-7 efficiently generate both Type I and Type II reactive oxygen species, and their photodynamic activity, combined with preferential mitochondrial accumulation, leads to potent nanomolar phototoxicity against CT-26 colorectal cancer cells under deep-red and NIR irradiation, even under hypoxia. Notably, the lead complex Ru6 demonstrated strong in vivo phototoxicity in mice bearing subcutaneous CT-26 tumors, achieving significant tumor growth inhibition upon irradiation with 660 and 780 nm light. Ru6 thus represents one of the first Ru(II) polypyridyl complexes to exhibit robust in vivo PDT antitumor activity under one-photon NIR activation. Its broad wavelength activation profile further underscores its potential versatility for treating tumors of varying size and anatomical location depending on specific light penetration requirements. These findings mark a promising step toward next-generation PSs for treating deep-seated and hypoxic tumors.

20 December 2025 in JACS Au
Verified
Journal Article
Open access
PAPezhman Ashoo
Pezhman Ashoo
AHAlba Hernández-García
Alba Hernández-García
EGEduardo Izquierdo García
Eduardo Izquierdo García
NSNeus Santiago
Neus Santiago
RMRebeca Mondaray-Marín
Rebeca Mondaray-Marín
VMVicente Marchán
Vicente Marchán
Ferroptosis, a recently described form of regulated, nonapoptotic cell death mechanism, presents significant potential for cancer treatment, particularly when combined with photodynamic therapy (PDT). In this study, we report the synthesis and biological evaluation of a series of Ir-COUBPY complexes as novel photosensitizers (PSs) for effective cancer phototherapy. These complexes exhibit high stability under both dark and light conditions and are capable of photogenerating Type I and Type II reactive oxygen species (ROS), as well as photo-oxidizing NADH. Electron paramagnetic resonance (EPR) spectroscopy provided direct evidence of light-induced superoxide and singlet oxygen generation, confirming dual ROS pathways. Moreover, the Ir-COUBPY complexes preferentially accumulated in the mitochondria of cancer cells, leading to the photogeneration of hydroxyl radicals and hydrogen peroxide. Photocytotoxicity studies on HeLa and A375 cancer cells underscored the role of the COUBPY ligand in enhancing PDT efficiency upon irradiation with both green and red light. Among the Ir-COUBPY complexes, the most effective PS, Ir4a, was encapsulated in polyurethane–polyurea hybrid nanocapsules (NC-Ir4a), resulting in a significant increase in phototoxic index values (e.g., from 64 to 179.6 in A375 cells). Mechanistic studies confirmed ferroptosis as the primary cell death pathway induced by Ir4a, supported by light-dependent lipid peroxidation, glutathione oxidation and depletion, intracellular ATP photodepletion, and the viability-restoring effect of Fer-1. These effects were more pronounced upon nanoencapsulation. Photobiological studies with 3D tumor spheroids of A375 cells further confirmed higher cellular uptake of NC-Ir4a, contributing to improved phototoxic efficiency. Overall, these findings highlight the potential of coumarin-based COUBPY ligands in the design of new Ir­(III)-based PSs that can be activated with light within the phototherapeutic window, operating through nonconventional cell death mechanisms such as ferroptosis.

4 May 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KCKarla Cevallos
Karla Cevallos
JAJose Luis Abad
Jose Luis Abad
BBBohdan Babiy
Bohdan Babiy
SLSilvia Sacristán López
Silvia Sacristán López
AHAlvaro Hidalgo-Llorente
Alvaro Hidalgo-Llorente
OPOscar Pastor
Oscar Pastor

23 June 2026 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
DADiego Abad‐Montero
Diego Abad‐Montero
MBManel Bosch
Manel Bosch
RGRodrigo Garcés‐Castellanos
Rodrigo Garcés‐Castellanos
MSMichael Q. Schottenhamel
Michael Q. Schottenhamel
SPSergio Pedraza-Arevalo
Sergio Pedraza-Arevalo
VMVicente Marchán
Vicente Marchán
Fluorescent probes operating in the near‐infrared (NIR) region offer deep‐tissue visualization with minimal background interference, reduced phototoxicity, and enhanced signal‐to‐noise ratios. However, most conventional NIR fluorophores exhibit poor photostability, low fluorescence quantum yields, and limited chemical versatility, which constrain their use in demanding biological environments. Here, we report a new family of π‐extended COUPY dyes ( 3 – 7 ), rationally engineered to deliver efficient far‐red/NIR performance through vinylogation of the exocyclic double bond of the coumarin scaffold. This single structural modification induces a bathochromic shift exceeding 100 nm in both absorption and emission spectra while preserving the compact architecture and synthetic accessibility of the parent coumarin. The resulting dyes combine high molar absorptivity, moderate‐to‐high quantum yields, and exceptional photostability under biologically‐relevant conditions. Their performance was validated in live‐cell imaging using both intensity‐based and fluorescence lifetime imaging microscopy (FLIM), demonstrating compatibility with advanced imaging techniques. Furthermore, site‐specific bioconjugation to a clinically relevant peptide confirmed their suitability for targeted imaging. Collectively, π‐extended COUPY dyes represent a promising class of synthetically modular, chemically robust, and biologically compatible far‐red/NIR fluorophores for high‐resolution imaging, targeted strategies, and advanced bioimaging modalities, and provide a foundation for future studies aimed at evaluating their performance in more complex biological models.